Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose methylprednisolone effects on exercise-induced fatigability in multiple sclerosis relapse
2007-002179-15Phase 4Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of methylprednisolone in multiple sclerosis (MS) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: Electrophysiological measurement variables and Correlation of electrophysiological and clinical changes. Started Nov 2007; status: active.
02
Drugs
methylprednisolone
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2007-002179-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002179-15.